| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0968-0896(01)00148-1 |
| P698 | PubMed publication ID | 11597457 |
| P50 | author | Michael D. B. Swedberg | Q42842832 |
| P2093 | author name string | Andersen KE | |
| Lau J | |||
| Petersen H | |||
| Suzdak PD | |||
| Huusfeldt PO | |||
| Lundt BF | |||
| P2860 | cites work | Cloning of the human brain GABA transporter | Q24310628 |
| Tiagabine pharmacology in profile | Q28275570 | ||
| Cloning and expression of a rat brain GABA transporter | Q28566313 | ||
| Rapid chromatographic technique for preparative separations with moderate resolution | Q29391396 | ||
| Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents. | Q30322944 | ||
| The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate | Q34062044 | ||
| Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. | Q34318256 | ||
| GABA uptake inhibitors: relevance to antiepileptic drug research | Q39488679 | ||
| Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations | Q39544980 | ||
| GABA synaptic mechanisms: stereochemical and conformational requirements | Q39629796 | ||
| Inhibitory, GABAergic Nerve Terminals Decrease at Sites of Focal Epilepsy | Q39667726 | ||
| .gamma.-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects | Q40085780 | ||
| Problems of delivery of drugs to the brain | Q40255856 | ||
| A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor | Q40412354 | ||
| Update on the mechanism of action of antiepileptic drugs | Q41240609 | ||
| Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3. | Q41453908 | ||
| GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representative | Q41929083 | ||
| Orally active and potent inhibitors of gamma-aminobutyric acid uptake | Q42204834 | ||
| Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor | Q43838084 | ||
| (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier | Q44799223 | ||
| Prophylaxis of amygdala kindling-induced epileptogenesis: comparison of a GABA uptake inhibitor and diazepam | Q45149919 | ||
| Inhibition by Neuroleptics of Uptake of 3H-GABA into Rat Brain Synaptosomes | Q48232240 | ||
| Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake | Q48418395 | ||
| Effects of THIP on chronic anxiety. | Q48830585 | ||
| A GABA transporter cDNA has been cloned. | Q48856946 | ||
| GABA transporter protein cloned from rat brain. | Q48863993 | ||
| Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus. | Q49050748 | ||
| Synthesis and cytotoxic evaluation of some 6-arylidene-2-(alpha-hydroxyamino-alpha-arylmethyl)cyclohexanone oximes and related compounds | Q67590632 | ||
| GABA agonists and uptake inhibitors. Synthesis, absolute stereochemistry, and enantioselectivity of (R)-(-)- and (S)-(+)-homo-beta-proline | Q68447118 | ||
| Substituted (omega-aminoalkoxy) stilbene derivatives as a new class of anticonvulsants | Q71330073 | ||
| Studies on gamma-aminobutyric acid transport in cobalt experimental epilepsy in the rat | Q71538702 | ||
| Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses | Q71734583 | ||
| Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates | Q73138368 | ||
| Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake | Q93572886 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2773-2785 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives | |
| P478 | volume | 9 |
| Q41439937 | A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1) |
| Q34161411 | Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-α-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae-Papilionaceae). |
| Q41890150 | Classification of High-Activity Tiagabine Analogs by Binary QSAR Modeling |
| Q86938754 | Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives by Suzuki-Miyaura Cross-Coupling Reactions |
| Q35393157 | Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1. |
| Q93371213 | Identification of Pyrrolidine-3-acetic Acid Derived Oximes as Potent Inhibitors of γ-Aminobutyric Acid Transporter 1 through Library Screening with MS Binding Assays |
| Q34300638 | Library screening by means of mass spectrometry (MS) binding assays-exemplarily demonstrated for a pseudostatic library addressing γ-aminobutyric acid (GABA) transporter 1 (GAT1). |
| Q46450656 | Nipecotic acid: systemic availability and brain delivery after nasal administration of nipecotic acid and n-butyl nipecotate to rats |
| Q60950396 | Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy |
| Q36020907 | Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships |
| Q36686930 | Structure-activity relationship and pharmacology of gamma-aminobutyric acid (GABA) transport inhibitors. |
| Q92921913 | Synthesis and Biological Evaluation of Nipecotic Acid and Guvacine Derived 1,3-Disubstituted Allenes as Inhibitors of Murine GABA Transporter mGAT1 |
Search more.